ULOQ [Study As­sess­ment]

posted by Anand – India, 2017-10-30 06:38  – Posting: # 17945
Views: 6,409

Dear All,

Request to clarify,

In our Pivotal BE Study ULOQ was observed, whether we should exclude from PK?
After Dilution also it found ULOQ.
Method should be redeveloped or revalidated?
If included,What justification we should provide to Regulatory Agency?

Thanks in advance.

Regards,
A.A


Edit: Category changed; see also this post #1. [Helmut]

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
19,983 posts in 4,228 threads, 1,373 registered users;
online 15 (1 registered, 14 guests [including 10 identified bots]).
Forum time (Europe/Vienna): 06:35 CET

To know the history of science is to recognize the mortality
of any claim to universal truth.    Evelyn Fox Keller

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5